Shiva Cement Regulatory Approval

Credit Rating

Shiva Cement Credit Rating

Crisil reaffirmed long-term credit ratings of A+/Stable and AA-(CE)/Stable for Shiva Cement's bank loan facilities. The ratings remain unchanged with stable outlook across all six facilities.

Financial Results

Shiva Cement Q2 FY27 Results: Net Loss of ₹22.9 Cr, Loss Narrows

Shiva Cement Ltd reported revenue from operations of ₹112.7 Cr (+37.3% YoY) and a net loss of ₹22.9 Cr for Q2 FY27.

Key figure

Net loss ₹22.9 Cr

Other Announcement

Shiva Cement Other Announcement

Shiva Cement Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing details the current equity shareholding distribution.

Board Meeting Date

Shiva Cement Board Meeting Date

Shiva Cement Limited has scheduled a board meeting for October 23, 2026. The board will primarily consider and approve unaudited financial results for the quarter ended September 2026.

Other Announcement

Shiva Cement Other Announcement

Shiva Cement Ltd submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, received from its RTA for the quarter ended September 30, 2026.

Acquisition

Shiva Cement Acquisition

Shiva Cement Ltd approved a Scheme of Arrangement for its amalgamation into JSW Cement Ltd. Shareholders will receive 5 shares of JSW Cement for every 41 held.

Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAPAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.

Regulatory ApprovalBliss GVS Pharma Ltd BLISSGVSAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Bliss GVS Pharma Regulatory Approval

Bliss GVS Pharma's UK subsidiary Asterisk Lifesciences received MHRA marketing authorisation for Mesalazine 1g Suppositories. The approval lets the subsidiary market the product in the UK.

Regulatory ApprovalJohn Cockerill India Ltd COCKERILLAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

John Cockerill India Regulatory Approval

John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.